Cargando…
LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancer
Background: Breast cancer (BRCA) represents the most frequent diagnosed malignancy in women worldwide. Despite treatment advances, BRCAs eventually develop resistance to targeted therapies, resulting in poor prognosis. The identification of new biomarkers, like immune-related long non-coding RNAs (l...
Autores principales: | Fonseca-Montaño, Marco Antonio, Cisneros-Villanueva, Mireya, Coales, Isabelle, Hidalgo-Miranda, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228735/ https://www.ncbi.nlm.nih.gov/pubmed/37260772 http://dx.doi.org/10.3389/fgene.2023.1034569 |
Ejemplares similares
-
Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis
por: Du, Wenjun, et al.
Publicado: (2019) -
Long non-coding RNA LINC00426 contributes to doxorubicin resistance by sponging miR-4319 in osteosarcoma
por: Wang, Lulin, et al.
Publicado: (2020) -
Linc00426 accelerates lung adenocarcinoma progression by regulating miR-455-5p as a molecular sponge
por: Li, Hongli, et al.
Publicado: (2020) -
PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B
por: Raj-Kumar, Praveen-Kumar, et al.
Publicado: (2019) -
CrisPam: SNP-Derived PAM Analysis Tool for Allele-Specific Targeting of Genetic Variants Using CRISPR-Cas Systems
por: Rabinowitz, Roy, et al.
Publicado: (2020)